Psychosocial Impact of the Bionic Pancreas During Summer Camp

Authors: Weissberg-Benchell, J., Hessler, D., Polonsky, WH., Fisher, L.

Abstract

Background: The psychosocial impact of the bionic pancreas (BP) was assessed among children attending diabetes camp.

Methods: Nineteen children were randomly assigned for 5 days to the BP condition and 5 days to the control condition in a crossover design.

Results: Significant reductions in hypoglycemic fear and regimen burden were found. Children felt less burdened or worried about diabetes and felt freer to do things they enjoyed while using the BP. Children wished the BP responded to out of range numbers faster and expressed annoyance about carrying around the necessary equipment.

Conclusions: Children may experience improved psychosocial outcomes following use of BP while expressing key areas of user concern. Future studies in less controlled environments with larger sample sizes can determine if these findings are generalizable to other groups.

Source: https://pubmed.ncbi.nlm.nih.gov/26993252/

Share the Post:

BDI Monthly Events

September 9
September 9Case Consultation
September 9: BDI hosts the San Diego-wide, monthly case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at info@behavioraldiabetes.org if you are in the greater San Diego area and would like further information about this program.
October 16
October 16Diabetes Data Workshop
BDI friends and fellow healthcare professionals, Adam Brown and Aimeé José, present an in-person half-day workshop for people with diabetes here in San Diego, How to Make Diabetes Data Your Friend. Don’t miss it!
October 24
October 24CME Workshop
On October 24, BDI will host a live, one-day, CME workshop: Engaging the Disengaged: Innovative Strategies for Promoting Behavior Change in Diabetes. Run by Dr. Polonsky (BDI President) and Dr. Guzman (BDI Clinic Director), Participants will deepen their skills in recognizing and addressing common barriers to effective self-care and cardiometabolic medication initiation and maintenance, while fostering respectful, stigma-free clinical encounters.